Cosmo Pharmaceuticals N.V. (SWX:COPN)

Market Cap	1.05B
Revenue (ttm)	178.46M
Net Income (ttm)	66.99M
Shares Out	16.05M
EPS (ttm)	4.16
PE Ratio	15.80
Forward PE	9.31
Dividend	1.88 (2.86%)
Ex-Dividend Date	n/a

Volume	14,216
Average Volume	18,743
Open	66.30
Previous Close	65.70
Day's Range	66.30 - 66.80
52-Week Range	58.20 - 80.60
Beta	1.30
RSI	55.85
Earnings Date	Mar 6, 2025

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1997
• Employees: 325
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: COPN

Financial Performance

Financial numbers in EUR